News Harm Reduction Therapeutics In The News The latest stories and news about Harm Reduction Therapeutics, OTC RiVive™, and naloxone Drug Intervention Institute partners with Harm Reduction Therapeutics to provide low-cost life-saving RiVive™ 3 mg naloxone nasal spray inside ONEbox™ Mar 1, 2024 Higher naloxone doses have no impact on overdose survival, study shows Feb 8, 2024 Open Society Supports an Innovative Model to Make Naloxone Easier to Access Amidst the U.S. Overdose Crisis Dec 12, 2023 Narcan Now Available Over-the-counter – What to Know Sep 5, 2023 Partnership to Save Lives: Harm Reduction Therapeutics to donate 200,000 RiVive™ naloxone doses to Remedy Alliance for free distribution Aug 17, 2023 A new, cheaper naloxone is coming to pharmacy shelves, funded in part by Purdue Pharma’s bankruptcy Aug 17, 2023 FDA APPROVAL OF RiVIVE™ IS A CRITICAL MILESTONE IN MAKING EMERGENCY TREATMENT OF OPIOID OVERDOSE MORE WIDELY AVAILABLE Aug 1, 2023 Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose Apr 11, 2023 Harm Reduction Therapeutics and Catalent Sign Commercial Supply Agreement for Naloxone Nasal Spray Mar 24, 2023 Load More
